Holen Sie sich die Stockscreener-App
1.27
0.00%
0.00
Handel nachbörslich:
1.27
Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten
IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates - MSN
Sectors Driving Future Growth for Ironwood Pharmaceuticals Inc. StockTrade Volume Report & Real-Time Sentiment Analysis - Newser
Historical volatility pattern of Ironwood Pharmaceuticals Inc. visualizedJuly 2025 Opening Moves & Short-Term High Return Ideas - Newser
Measuring Ironwood Pharmaceuticals Inc.’s beta against major indicesMarket Rally & Entry Point Confirmation Alerts - Newser
Ironwood Pharmaceuticals Inc. Earnings Report Breakdown: What Investors Should KnowWeekly Stock Recap & Daily Oversold Bounce Ideas - Newser
Keep An Eye On Ironwood Pharmaceuticals As Insider Stock Selling Hits US$515k - simplywall.st
Will Ironwood Pharmaceuticals Inc. benefit from rate cuts2025 Top Gainers & Stepwise Entry and Exit Trade Signals - classian.co.kr
Volume spikes in Ironwood Pharmaceuticals Inc. stock – what they meanWeekly Market Report & AI Forecasted Entry/Exit Points - Newser
How to build a custom watchlist for Ironwood Pharmaceuticals Inc.Trade Risk Summary & Safe Entry Zone Identification - Newser
Risk adjusted return profile for Ironwood Pharmaceuticals Inc. analyzed2025 Investor Takeaways & AI Enhanced Trading Signals - Newser
Using fundamentals and technicals on Ironwood Pharmaceuticals Inc.Portfolio Return Summary & Weekly High Return Stock Opportunities - Newser
What to do if you’re stuck in Ironwood Pharmaceuticals Inc.Analyst Downgrade & Entry and Exit Point Strategies - Newser
Multi factor analysis applied to Ironwood Pharmaceuticals Inc.2025 Earnings Surprises & Stepwise Trade Signal Implementation - Newser
Published on: 2025-08-15 04:45:17 - Newser
Can Ironwood Pharmaceuticals Inc. be recession proofJuly 2025 Catalysts & Safe Entry Momentum Tips - classian.co.kr
Ironwood Pharmaceuticals Inc. Uptrend in Early Stages Indicators Say YesJuly 2025 Summary & AI Enhanced Trading Signals - newsyoung.net
Published on: 2025-08-14 14:41:22 - beatles.ru
Can Ironwood Pharmaceuticals Inc. expand its profit margins2025 Performance Recap & Verified Entry Point Detection - 선데이타임즈
Analysts’ Opinions Are Mixed on These Healthcare Stocks: 89bio (ETNB), Relay Therapeutics (RLAY) and Ironwood Pharma (IRWD) - The Globe and Mail
Short Bowel Syndrome Market to Experience Notable Growth - openPR.com
Short Bowel Syndrome Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Zealand Pharma, Ironwood Pharma, Hanmi Pharma, Shire, AbbVie, Hanmi Pharma - Barchart.com
How high can Ironwood Pharmaceuticals Inc. stock goSmart Entry Signals for Active Traders - Newser
Ironwood Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Ironwood: Q2 Earnings Snapshot - Connecticut Post
Ironwood Pharmaceuticals Reports Strong Q2 2025 Results - TipRanks
Ironwood (IRWD) Q2 EPS Jumps 600% - AOL.com
Ironwood Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Ironwood Pharmaceuticals (IRWD.O) Surges 15.5% on Strong KDJ Signal Amid Mixed Peer Performance - AInvest
Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance - BioSpace
Ironwood Pharmaceuticals Q2 2025 Earnings: EPS of $0.15 and Reve - GuruFocus
Ironwood Pharmaceuticals Tops Expectations With Strong Q2 Results - Finimize
Ironwood Pharmaceuticals (IRWD) Projected to Post Quarterly Earnings on Thursday - Defense World
Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences - The Globe and Mail
Ironwood Pharmaceuticals Inc expected to post earnings of 4 cents a shareEarnings Preview - TradingView
Custom Dashboard Highlights Ironwood Pharmaceuticals Inc. Price MomentumFundamental Growth Stock Analysis Shows Strength - beatles.ru
Published on: 2025-08-04 00:15:09 - Jammu Links News
What drives Ironwood Pharmaceuticals Inc. stock priceExpert guidance for superior capital growth - Jammu Links News
Is Ironwood Pharmaceuticals Inc. stock overvalued or undervaluedAchieve rapid portfolio growth with expert guidance - Jammu Links News
Is it the right time to buy Ironwood Pharmaceuticals Inc. stockOutstanding risk-reward balance - Jammu Links News
Is Ironwood Pharmaceuticals Inc. a growth stock or a value stockDiscover stocks with strong growth potential - Jammu Links News
What are the technical indicators suggesting about Ironwood Pharmaceuticals Inc.Build a winning investment strategy - Jammu Links News
What are the latest earnings results for Ironwood Pharmaceuticals Inc.Unprecedented growth rates - Jammu Links News
What catalysts could drive Ironwood Pharmaceuticals Inc. stock higher in 2025Achieve breakthrough financial growth - Jammu Links News
How strong is Ironwood Pharmaceuticals Inc. company’s balance sheetDynamic portfolio growth - Jammu Links News
What makes Ironwood Pharmaceuticals Inc. stock price move sharplyExceptional financial outcomes - Jammu Links News
What Fibonacci levels say about Ironwood Pharmaceuticals Inc. reboundAutomated AI Forecast with Trading Alerts - Newser
0.07%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):